KY-1051

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameKY-1051
Drug Alias NameKY-1051
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-C-X-C motif chemokine receptor 4
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma UK LtdKymab Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKymab LtdNxera Pharma UK Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A